Xenon Pharmaceuticals Statistics

Total Valuation

XENE has a market cap or net worth of $3.22 billion. The enterprise value is $2.54 billion.

Market Cap	3.22B
Enterprise Value	2.54B

Important Dates

The next estimated earnings date is Wednesday, August 7, 2024, after market close.

Earnings Date	Aug 7, 2024
Ex-Dividend Date	n/a

Share Statistics

XENE has 75.47 million shares outstanding. The number of shares has increased by 18.06% in one year.

Shares Outstanding	75.47M
Shares Change (YoY)	+18.06%
Shares Change (QoQ)	+10.90%
Owned by Insiders (%)	0.38%
Owned by Institutions (%)	100.33%
Float	69.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.63
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 31.82, with a Debt / Equity ratio of 0.01.

Current Ratio	31.82
Quick Ratio	31.52
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -24.30% and return on invested capital (ROIC) is -24.95%.

Return on Equity (ROE)	-24.30%
Return on Assets (ROA)	-23.30%
Return on Capital (ROIC)	-24.95%
Revenue Per Employee	n/a
Profits Per Employee	-$728,174
Employee Count	259
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-170,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.14% in the last 52 weeks. The beta is 1.27, so XENE's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	+9.14%
50-Day Moving Average	39.00
200-Day Moving Average	40.38
Relative Strength Index (RSI)	63.71
Average Volume (20 Days)	499,336

Short Selling Information

The latest short interest is 3.05 million, so 4.04% of the outstanding shares have been sold short.

Short Interest	3.05M
Short Previous Month	3.06M
Short % of Shares Out	4.04%
Short % of Float	4.38%
Short Ratio (days to cover)	7.00

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-224.04M
Pretax Income	-188.77M
Net Income	-188.60M
EBITDA	-184.98M
EBIT	-188.77M
Earnings Per Share (EPS)	-$2.71

Full Income Statement

Balance Sheet

The company has $699.60 million in cash and $10.43 million in debt, giving a net cash position of $689.18 million or $9.13 per share.

Cash & Cash Equivalents	699.60M
Total Debt	10.43M
Net Cash	689.18M
Net Cash Per Share	$9.13
Equity (Book Value)	887.70M
Book Value Per Share	11.76
Working Capital	684.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$154.09 million and capital expenditures -$3.60 million, giving a free cash flow of -$157.69 million.

Operating Cash Flow	-154.09M
Capital Expenditures	-3.60M
Free Cash Flow	-157.69M
FCF Per Share	-$2.03

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XENE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.06%
Shareholder Yield	-18.06%
Earnings Yield	-5.85%
FCF Yield	-4.89%

Dividend Details

Analyst Forecast

The average price target for XENE is $59.00, which is 38.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$59.00
Price Target Difference	38.08%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3